Clinical trial
Algorithmic Protamine Dosing for Reversal of Heparin After Cardiopulmonary Bypass (PRODOSE)
NCT03532594 is registered in ClinicalTrials.gov with Papworth Hospital NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Algorithmic Protamine Dosing for Reversal of Heparin After Cardiopulmonary Bypass (PRODOSE)
- Lead sponsor
- Papworth Hospital NHS Foundation Trust
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 16, 2018
- Completion date
- January 30, 2020
- Enrollment
- 228 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.